Systematic review seeking erythropoietin role for neuroprotection in neonates with hypoxic ischemic encephalopathy: presently where do we stand

References

• Executive summary: neonatal encephalopathy and neurologic outcome, second edition. Report of the American College of Obstetricians and Gynecologists’ Task Force on Neonatal Encephalopathy. Obstet Gynecol. 2014;123(4):896–901.
   PubMedGoogle Scholar
• Choudhary M, Sharma D, Dabi D, et al. Hepatic dysfunction in asphyxiated neonates: prospective case-controlled study. Clin Med Insights Pediatr. 2015;9:1–6.
   PubMedGoogle Scholar
• Sharma D, Choudhary M, Lamba M, et al. Correlation of Apgar score with asphyxial hepatic injury and mortality in newborns: a prospective observational study from India. Clin Med Insights Pediatr. 2016;10:27–34.
   PubMedGoogle Scholar
• Wyllie J, Perlman JM, Kattwinkel J, et al. Part 7: Neonatal resuscitation: 2015 international consensus on cardiopulmonary resuscitation and emergency cardiovascular care science with treatment recommendations. Resuscitation. 2015;95:e169–e201.
   PubMed Web of Science ®Google Scholar
• Black RE, Cousens S, Johnson HL, et al. Global, regional, and national causes of child mortality in 2008: a systematic analysis. Lancet. 2010;375(9730):1969–1987.
   PubMed Web of Science ®Google Scholar
• Pin TW, Eldridge B, Galea MP. A review of developmental outcomes of term infants with post-asphyxia neonatal encephalopathy. Eur J Paediatr Neurol. 2009;13(3):224–234.
   PubMed Web of Science ®Google Scholar
• Jacobs SE, Berg M, Hunt R, et al. Cooling for newborns with hypoxic ischaemic encephalopathy. Cochrane Database Syst Rev. 2013;1:CD003311.
   PubMed Web of Science ®Google Scholar
• Carnot P, Deflandre O Sur l’activite hematopoietique des differents organes au cours de la regeneration du sang. Comt Rend Academy Sci. 1906;143:432–435.
   Google Scholar
• Maiese K, Chong ZZ, Hou J, et al. Erythropoietin and oxidative stress. Curr Neurovasc Res. 2008;5(2):125–142.
   PubMed Web of Science ®Google Scholar
• Villa P, van Beek J, Larsen AK, et al. Reduced functional deficits, neuroinflammation, and secondary tissue damage after treatment of stroke by nonerythropoietic erythropoietin derivatives. J Cereb Blood Flow Metab. 2007;27(3):552–563.
   PubMed Web of Science ®Google Scholar
• Juul SE, Yachnis AT, Christensen RD. Tissue distribution of erythropoietin and erythropoietin receptor in the developing human fetus. Early Hum Dev. 1998;52(3):235–249.
   PubMed Web of Science ®Google Scholar
• Marti HH, Wenger RH, Rivas LA, et al. Erythropoietin gene expression in human, monkey and murine brain. Eur J Neurosci. 1996;8(4):666–676.
   PubMed Web of Science ®Google Scholar
• Digicaylioglu M, Bichet S, Marti HH, et al. Localization of specific erythropoietin binding sites in defined areas of the mouse brain. Proc Natl Acad Sci USA. 1995;92(9):3717–3720.
   PubMed Web of Science ®Google Scholar
• Nagai A, Nakagawa E, Choi HB, et al. Erythropoietin and erythropoietin receptors in human CNS neurons, astrocytes, microglia, and oligodendrocytes grown in culture. J Neuropathol Exp Neurol. 2001;60(4):386–392.
   PubMed Web of Science ®Google Scholar
• Yamaji R, Okada T, Moriya M, et al. Brain capillary endothelial cells express two forms of erythropoietin receptor mRNA. Eur J Biochem. 1996;239(2):494–500.
   PubMedGoogle Scholar
• Brines ML, Ghezzi P, Keenan S, et al. Erythropoietin crosses the blood–brain barrier to protect against experimental brain injury. Proc Natl Acad Sci USA. 2000;97(19):10526–10531.
   PubMed Web of Science ®Google Scholar
• Juul SE, McPherson RJ, Farrell FX, et al. Erythropoietin concentrations in cerebrospinal fluid of nonhuman primates and fetal sheep following high-dose recombinant erythropoietin. Biol Neonate. 2004;85(2):138–144.
   PubMedGoogle Scholar
• Juul SE, Harcum J, Li Y, et al. Erythropoietin is present in the cerebrospinal fluid of neonates. J Pediatr. 1997;130(3):428–430.
   PubMed Web of Science ®Google Scholar
• Statler PA, McPherson RJ, Bauer LA, et al. Pharmacokinetics of high-dose recombinant erythropoietin in plasma and brain of neonatal rats. Pediatr Res. 2007;61(6):671–675.
   PubMed Web of Science ®Google Scholar
• McPherson RJ, Demers EJ, Juul SE. Safety of high-dose recombinant erythropoietin in a neonatal rat model. Neonatology. 2007;91(1):36–43.
   PubMed Web of Science ®Google Scholar
• Bernaudin M, Nedelec AS, Divoux D, et al. Normobaric hypoxia induces tolerance to focal permanent cerebral ischemia in association with an increased expression of hypoxia-inducible factor-1 and its target genes, erythropoietin and VEGF, in the adult mouse brain. J Cereb Blood Flow Metab. 2002;22(4):393–403.
   PubMed Web of Science ®Google Scholar
• McAdams RM, Juul SE. Neonatal encephalopathy update on therapeutic hypothermia and other novel therapeutics. Clin Perinatol. 2016;43(3):485–500.
   PubMed Web of Science ®Google Scholar
• Lipton P. Ischemic cell death in brain neurons. Physiol Rev. 1999;79(4):1431–1568.
   PubMed Web of Science ®Google Scholar
• Silva M, Grillot D, Benito A, et al. Erythropoietin can promote erythroid progenitor survival by repressing apoptosis through bcl-xl and bcl-2. Blood. 1996;88(5):1576–1582.
   PubMed Web of Science ®Google Scholar
• Morishita E, Masuda S, Nagao M, et al. Erythropoietin receptor is expressed in rat hippocampal and cerebral cortical neurons, and erythropoietin prevents in vitro glutamate-induced neuronal death. Neuroscience. 1997;76(1):105–116.
   PubMed Web of Science ®Google Scholar
• Sun Y, Calvert JW, Zhang JH. Neonatal hypoxia/ischemia is associated with decreased inflammatory mediators after erythropoietin administration. Stroke. 2005;36(8):1672–1678.
   PubMed Web of Science ®Google Scholar
• Marti HH, Bernaudin M, Petit E, et al. Neuroprotection and angiogenesis: dual role of erythropoietin in brain ischemia. News Physiol Sci. 2000;15:225–229.
   PubMedGoogle Scholar
• Tsai PT, Ohab JJ, Kertesz N, et al. A critical role of erythropoietin receptor in neurogenesis and post-stroke recovery. J Neurosci. 2006;26(4):1269–1274.
   PubMed Web of Science ®Google Scholar
• Shingo T, Sorokan ST, Shimazaki T, et al. Erythropoietin regulates the in vitro and in vivo production of neuronal progenitors by mammalian forebrain neural stem cells. J Neurosci. 2001;21(24):9733–9743.
   PubMed Web of Science ®Google Scholar
• Iwai M, Stetler RA, Xing J, et al. Enhanced oligodendrogenesis and recovery of neurological function by erythropoietin after neonatal hypoxic/ischemic brain injury. Stroke. 2010;41(5):1032–1037.
   PubMed Web of Science ®Google Scholar
• Azzopardi D, Robertson NJ, Bainbridge A, et al. Moderate hypothermia within 6 h of birth plus inhaled xenon versus moderate hypothermia alone after birth asphyxia (TOBY-Xe): a proof-of-concept, open-label, randomised controlled trial. Lancet Neurol. 2016;15(2):145–153.
   PubMed Web of Science ®Google Scholar
• Aly H, Elmahdy H, El-Dib M, et al. Melatonin use for neuroprotection in perinatal asphyxia: a randomized controlled pilot study. J Perinatol. 2015;35(3):186–191.
   PubMed Web of Science ®Google Scholar
• Martinello K, Hart AR, Yap S, et al. Management and investigation of neonatal encephalopathy: 2017 update. Arch Dis Child Fetal Neonatal Ed. 2017;102(4):F346–F358.
   PubMed Web of Science ®Google Scholar
• Zhu C, Kang W, Xu F, et al. Erythropoietin improved neurologic outcomes in newborns with hypoxic- ischemic encephalopathy. Pediatrics. 2009;124(2):e218–ee226.
   PubMed Web of Science ®Google Scholar
• Elmahdy H, El-Mashad AR, El-Bahrawy H, et al. Human recombinant erythropoietin in asphyxia neonatorum: pilot trial. Pediatrics. 2010;125(5):e1135–e1142.
   PubMed Web of Science ®Google Scholar
• Malla RR, Asimi R, Teli MA, et al. Erythropoietin monotherapy in perinatal asphyxia with moderate to severe encephalopathy: a randomized placebo-controlled trial. J Perinatol. 2017;37(5):596–601.
   PubMed Web of Science ®Google Scholar
• El Shimi MS, Awad HA, Hassanein SM, et al. Single dose recombinant erythropoietin versus moderate hypothermia for neonatal hypoxic ischemic encephalopathy in low resource settings. J Matern Fetal Neonatal Med. 2014;27(13):1295–1300.
   PubMed Web of Science ®Google Scholar
• Wang YJ, Pan KL, Zhao XL, et al. Therapeutic effects of erythropoietin on hypoxic-ischemic encephalopathy in neonates. Zhongguo Dang Dai Er Ke Za Zhi. 2011;13(11):855–858.
   PubMedGoogle Scholar
• Rogers EE, Bonifacio SL, Glass HC, et al. Erythropoietin and hypothermia for hypoxic-ischemic encephalopathy. Pediatr Neurol. 2014;51(5):657–662.
   PubMed Web of Science ®Google Scholar
• Avasiloaiei A, Dimitriu C, Moscalu M, et al. High-dose phenobarbital or erythropoietin for the treatment of perinatal asphyxia in term newborns. Pediatr Int. 2013 Oct;55(5):589–593.
   PubMed Web of Science ®Google Scholar
• Valera IT, Vázquez MD, Gonzalez MD, et al. Erythropoietin with hypothermia improves outcomes in neonatal hypoxic ischemic encephalopathy. J Clin Neonatol. 2015;4:244–249.
   Web of Science ®Google Scholar
• Wu YW, Mathur AM, Chang T, et al. High-dose erythropoietin and hypothermia for hypoxic-ischemic encephalopathy: a Phase II Trial. Pediatrics. 2016;137(6):e20160191.
   PubMed Web of Science ®Google Scholar
• Patkai, et al. Phase III study of efficacy of high dose erythropoietin to prevent hypoxic-ischemic encephalopathy sequelae in term newborn. ClinicalTrials.gov Identifier:NCT01732146.
   Google Scholar
• Liley, et al. Preventing adverse outcomes of neonatal hypoxic ischaemic encephalopathy with erythropoietin: A Phase III randomised placebo controlled multicentre clinical trial. ClinicalTrials.gov Identifier: NCT03079167.
   Google Scholar
• Wu, et al. High-dose erythropoietin for asphyxia and encephalopathy. ClinicalTrials.gov Identifier: NCT02811263.
   Google Scholar
• Wu YW, Bauer LA, Ballard RA, et al. Erythropoietin for neuroprotection in neonatal encephalopathy: safety and pharmacokinetics. Pediatrics. 2012;130(4):683–691.
   PubMed Web of Science ®Google Scholar
• Kellert BA, McPherson RJ, Juul SE. A comparison of high-dose recombinant erythropoietin treatment regimens in brain- injured neonatal rats. Pediatr Res. 2007;61(4):451–455.
   PubMed Web of Science ®Google Scholar
• Baserga MC, Beachy JC, Roberts JK, et al. Darbepoetin administration to neonates undergoing cooling for encephalopathy: a safety and pharmacokinetic trial. Pediatr Res. 2015;78(3):315–322.
   PubMed Web of Science ®Google Scholar